On May 7, 2025, GT Biopharma, Inc. increased its board of directors from four to six members, appointed Hilary Kramer as a new non-employee director, and reported resignations of Bruce Wendel and Rajesh Shrotriya, reducing the board back to four members on May 12, 2025.